CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Medical/surgical maskWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1544 N95 Respirator Wiki 1.00

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D018184 Paramyxoviridae Infections NIH 0.58

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Incidence of Respiratory Illness in Outpatient Healthcare Workers Who Wear Respirators or Medical Masks While Caring for Patients

Despite widespread use of respiratory protective equipment in the U.S. healthcare workplace, there is very little clinical evidence that respirators prevent healthcare personnel (HCP) from airborne infectious diseases. Scientific investigation of this issue has been quite complicated, primarily because the use of respirators has become "the standard of care" for protection against airborne diseases in some instances, even without sufficient evidence to support their use. The key question remains: How well do respirators prevent airborne infectious diseases? The answer to this important question has important medical, public health, political and economic implications.

NCT01249625 Influenza Respiratory Syncytial Viruses Paramyxoviridae Infections Coronavirus Rhinovirus Device: N95 Respirator Device: Medical/surgical mask
MeSH:Paramyxoviridae Infections

Primary Outcomes

Description: Number of influenza A and B events in healthcare practitioners wearing N95 respirators compared to medical masks.

Measure: Protective Effects of N95 Respirators vs Medical Masks (MM) as Assessed by Number of Influenza A and B Events

Time: 60 weeks

Secondary Outcomes

Description: Number of influenza-like illnesses in healthcare practitioners wearing N95 respirators compared to medical masks.

Measure: Protective Effects of N95 Respirators vs Medical Masks as Assessed by Number of Influenza-like Illnesses

Time: 60 weeks

Description: Number of lab confirmed respiratory illnesses in healthcare practitioners wearing N95 respirators compared to medical masks.

Measure: Protective Effects of N95 Respirators vs Medical Masks as Assessed by Number of Lab Confirmed Respiratory Illnesses

Time: 60 weeks

Description: Number of lab detected respiratory infections in healthcare practitioners wearing N95 respirators compared to medical masks.

Measure: Protective Effects of N95 Respirators vs Medical Masks as Assessed by Number of Lab Detected Respiratory Infections

Time: 60 weeks

Description: Number of acute respiratory illnesses in healthcare practitioners wearing N95 respirators compared to medical masks.

Measure: Protective Effects of N95 Respirators vs Medical Masks as Assessed by Number of Acute Respiratory Illnesses

Time: 60 weeks

Description: Number of laboratory confirmed influenza illnesses in healthcare practitioners wearing N95 respirators compared to medical masks.

Measure: Protective Effects of N95 Respirators vs Medical Masks as Assessed by Number of Laboratory Confirmed Illness

Time: 60 weeks


No related HPO nodes (Using clinical trials)